GMED Holding B.V.

pending

 The proposed investment is a USD15M unsecured income participating loan, in GMED Holding B.V. (the “Company” under creation, or the “Borrower”), a holding medical technologies (“medtech”) manufacturing and distribution company, to support (i) growing its existing subsidiaries' operations in Egypt and (ii) the company's expansion into five East African countries, namely: Kenya, Tanzania, Uganda, Ethiopia, and Rwanda as a medtech distributor (“the Project”).Founded in 1983, the subsidiaries in Egypt (collectively known as “EGMED”) operate in the field of assembly, manufacturing, and distribution of medical equipment and consumables for hospitals and healthcare entities, including maintenance and servicing of equipment. Consumables manufactured include medical products used for dialysis equipment such as the Bloodline and Fistula needle. The disposables of dialysis devices are utilized with machines assembled by EGMED’s factory in 10th of Ramadan City processing plant. EGMED currently serves over 1,500 hospitals and large pharmacies chains all over Egypt. The company has built long-term partnerships with world leading healthcare manufacturers. As of December 2024, the company operates four manufacturing plants in Cairo Egypt in addition to nine distribution centers.